The U.S. Food and Drug Administration’s calendar for PDUFA dates is relatively quiet for the middle of July, although it picks up heading into August. Here’s a look at target action dates for the next two weeks.  

“Access to safe and effective treatment options is crucial for the significant number of Americans affected by severe alopecia,” said Kendall Marcus, M.D., director of the Division of Dermatology and Dentistry in the FDA’s Center for Drug Evaluation and Research, adding that the approval fulfills a significant unmet need for patients with severe alopecia areata.